Literature DB >> 19052853

Dietary and nutritional indications in hepatic encephalopathy.

Manuela Merli1, Oliviero Riggio.   

Abstract

The restriction of dietary protein has long been considered a main stay in the therapy of hepatic encephalopathy. More recently it has been recognized that protein energy malnutrition is frequent in advanced liver disease and may adversely affect the patients'outcome. Moreover studies on inter-organ ammonia exchange in liver cirrhosis have shown that the muscle may have a crucial role in ammonia detoxification. In light of these evidences nutritional guidelines have proposed that protein restriction should be avoided in patients with hepatic encephalopathy as protein requirement is even increased in cirrhotic patients. Survey about the current clinical practice show that protein restriction is still considered advisable in patients with hepatic encephalopathy, however a recent trial evidenced that a low protein diet in patients hospitalized for acute hepatic encephalopathy exacerbates protein breakdown without inducing any specific clinical benefit when compared to a normal protein regimen. The relevance of an adequate protein intake and possible strategies to implement protein tolerance are also discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052853     DOI: 10.1007/s11011-008-9127-0

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  48 in total

1.  Dietary management of hepatic encephalopathy in cirrhotic patients: survey of current practice in United Kingdom.

Authors:  C T Soulsby; M Y Morgan
Journal:  BMJ       Date:  1999-05-22

Review 2.  Protein restriction in hepatic encephalopathy: necessary evil or illogical dogma?

Authors:  Kevin D Mullen; Srinivasan Dasarathy
Journal:  J Hepatol       Date:  2004-07       Impact factor: 25.083

3.  [Comparison between a diet with mainly vegetal protein content and a diet with mainly animal protein content in hepatic cirrhosis].

Authors:  C Chiarino; A Frosi; F Vezzoli; M Sforza; M Rusca
Journal:  Minerva Gastroenterol Dietol       Date:  1992 Jan-Mar

4.  Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.

Authors:  Yasutoshi Muto; Shunichi Sato; Akiharu Watanabe; Hisataka Moriwaki; Kazuyuki Suzuki; Akinobu Kato; Masahiko Kato; Teiji Nakamura; Kiyohiro Higuchi; Shuhei Nishiguchi; Hiromitsu Kumada
Journal:  Clin Gastroenterol Hepatol       Date:  2005-07       Impact factor: 11.382

5.  Clinical comparison of branched-chain amino acid (l-Leucine, l-Isoleucine, l-Valine) granules and oral nutrition for hepatic insufficiency in patients with decompensated liver cirrhosis (LIV-EN study).

Authors:  Shunichi Sato; Akiharu Watanabe; Yasutoshi Muto; Kazuyuki Suzuki; Akinobu Kato; Hisataka Moriwaki; Masahiko Kato; Teiji Nakamura
Journal:  Hepatol Res       Date:  2005-03-23       Impact factor: 4.288

6.  Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests.

Authors:  P Amodio; F Del Piccolo; P Marchetti; P Angeli; R Iemmolo; L Caregaro; C Merkel; G Gerunda; A Gatta
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

7.  ESPEN Guidelines on Enteral Nutrition: Liver disease.

Authors:  M Plauth; E Cabré; O Riggio; M Assis-Camilo; M Pirlich; J Kondrup; P Ferenci; E Holm; S Vom Dahl; M J Müller; W Nolte
Journal:  Clin Nutr       Date:  2006-05-16       Impact factor: 7.324

8.  Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation.

Authors:  M Merli; F Leonetti; O Riggio; V Valeriano; M C Ribaudo; F Strati; G Tisone; C U Casciani; L Capocaccia; F Sprati
Journal:  Hepatology       Date:  1999-09       Impact factor: 17.425

9.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

10.  Splanchnic and leg exchange of free fatty acids in patients with liver cirrhosis.

Authors:  M Merli; L S Eriksson; L Hagenfeldt; J Wahren
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

View more
  6 in total

1.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

2.  Epidemiological and clinical features of hepatitis B virus related liver failure in China.

Authors:  Chen Liu; Yu-Ming Wang; Ke Fan
Journal:  World J Gastroenterol       Date:  2011-07-07       Impact factor: 5.742

Review 3.  Nutrition Assessment and Management in Patients with Cirrhosis and Cognitive Impairment: A Comprehensive Review of Literature.

Authors:  Jessica Faccioli; Silvia Nardelli; Stefania Gioia; Oliviero Riggio; Lorenzo Ridola
Journal:  J Clin Med       Date:  2022-05-18       Impact factor: 4.964

4.  Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study.

Authors:  Manuela Merli; Michela Giusto; Cristina Lucidi; Valerio Giannelli; Ilaria Pentassuglio; Vincenza Di Gregorio; Barbara Lattanzi; Oliviero Riggio
Journal:  Metab Brain Dis       Date:  2012-12-07       Impact factor: 3.584

5.  Role of nutrition in the management of hepatic encephalopathy in end-stage liver failure.

Authors:  Chantal Bémeur; Paul Desjardins; Roger F Butterworth
Journal:  J Nutr Metab       Date:  2010-12-22

Review 6.  A Comprehensive Review Evaluating the Impact of Protein Source (Vegetarian vs. Meat Based) in Hepatic Encephalopathy.

Authors:  Umair Iqbal; Ravirajsinh N Jadeja; Harshit S Khara; Sandeep Khurana
Journal:  Nutrients       Date:  2021-01-26       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.